Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 42.81%1.1B | 45.38%734.64M | 54.23%337.78M | 38.28%1.03B | 27.84%772.37M | 17.49%505.33M | 20.98%219.01M | 11.84%742.28M | 12.16%604.17M | 9.82%430.11M |
| Operating revenue | 42.81%1.1B | 45.38%734.64M | 54.23%337.78M | 38.28%1.03B | 27.84%772.37M | 17.49%505.33M | 20.98%219.01M | 11.84%742.28M | 12.16%604.17M | 9.82%430.11M |
| Total operating cost | 42.88%961.6M | 41.13%631.84M | 47.42%295.82M | 36.19%909.91M | 30.21%673.02M | 25.44%447.7M | 34.06%200.66M | 16.20%668.12M | 19.60%516.86M | 356.9M |
| Operating cost | 40.46%736.07M | 39.04%488.85M | 62.91%231.81M | 37.65%689.84M | 27.42%524.04M | 21.74%351.59M | 32.67%142.29M | 24.95%501.16M | 29.13%411.26M | --288.81M |
| Operating tax surcharges | -18.79%5.42M | -37.69%3M | -13.83%1.62M | 52.70%7.87M | 74.26%6.67M | 129.14%4.81M | 107.48%1.88M | 12.08%5.15M | 19.66%3.83M | --2.1M |
| Operating expense | 48.12%60.13M | 43.69%37.19M | -33.48%17.26M | 40.59%61.39M | 39.79%40.59M | 42.69%25.88M | 35.17%25.94M | -35.10%43.66M | -46.78%29.04M | --18.14M |
| Administration expense | 24.13%48.43M | 19.11%31.4M | 11.36%13.76M | 11.25%65.81M | 28.20%39.01M | 33.21%26.36M | 31.64%12.35M | 15.27%59.15M | 14.28%30.43M | --19.79M |
| Financial expense | 88.06%-816.29K | 82.24%-1.01M | 88.89%-463.72K | -263.67%-9.16M | -2,727.43%-6.84M | -927.46%-5.66M | -469.20%-4.17M | -209.53%-2.52M | -13.75%260.28K | --683.87K |
| -Interest expense (Financial expense) | 21.67%1.49M | 25.51%1.13M | 57.96%629.62K | -67.06%1.34M | --1.23M | -59.17%900.4K | -60.94%398.6K | 5.18%4.07M | ---- | --2.21M |
| -Interest Income (Financial expense) | 55.70%-4.01M | 57.37%-3.13M | 80.27%-1.01M | -85.10%-11.29M | ---9.06M | -487.12%-7.35M | -749.29%-5.12M | -1,001.85%-6.1M | ---- | ---1.25M |
| Research and development | 61.60%112.37M | 61.93%72.4M | 42.34%31.84M | 53.06%94.15M | 65.39%69.54M | 63.28%44.71M | 89.23%22.37M | 27.07%61.51M | 45.06%42.05M | --27.38M |
| Credit Impairment Loss | 4.74%-8.26M | -191.46%-13.46M | -192.71%-6.08M | -761.08%-9.85M | -5,532.60%-8.67M | -44.54%-4.62M | 66.66%-2.08M | 117.31%1.49M | 102.20%159.59K | ---3.2M |
| Asset Impairment Loss | -91.49%-21.61M | -81.22%-11.65M | -833.82%-3.19M | -168.64%-14.64M | -431.98%-11.29M | -1,293.23%-6.43M | 58.56%-341.27K | 41.95%-5.45M | 71.99%-2.12M | --538.98K |
| Other net revenue | ||||||||||
| Fair value change income | 23.54%6.98M | -5.94%4.96M | 15.06%3.2M | 10,579.65%7.08M | --5.65M | --5.27M | --2.78M | --66.25K | ---- | ---- |
| Invest income | -32.06%6.74M | -18.69%4.11M | -27.49%1.45M | --13.37M | --9.93M | --5.06M | --2M | ---- | ---- | ---- |
| Asset deal income | ---- | ---- | ---- | ---35.05K | ---35.05K | ---35.05K | ---35.05K | ---- | ---- | ---- |
| Other revenue | -78.04%10.64M | -70.38%9.3M | -95.92%512.48K | 4.70%55.86M | 33.14%48.46M | 75.63%31.39M | 86.96%12.56M | 76.32%53.35M | 122.86%36.4M | --17.87M |
| Operating profit | -5.19%135.95M | 8.83%96.06M | 13.88%37.85M | 36.18%168.33M | 17.79%143.4M | -0.18%88.26M | 7.18%33.23M | 22.40%123.61M | 12.73%121.74M | -1.55%88.42M |
| Add:Non operating Income | 122.53%40.75K | 458.90%27.95K | 4,188.30%214.48K | -99.80%19.36K | -99.81%18.31K | 12.76%5K | 398.16%5K | 10,059,022.99%9.64M | 10,070,583.74%9.64M | --4.44K |
| Less:Non operating expense | 93.34%535.19K | -55.82%96.49K | 498.72%80.23K | 17,204.20%586.06K | 11,191.53%276.81K | 8,808.87%218.4K | 446.61%13.4K | 9,935.05%3.39K | 7,551.34%2.45K | --2.45K |
| Total profit | -5.37%135.46M | 9.02%95.99M | 14.31%37.98M | 25.91%167.77M | 8.96%143.14M | -0.42%88.05M | 7.16%33.23M | 31.94%133.25M | 21.65%131.38M | -1.55%88.42M |
| Less:Income tax cost | -47.95%6.95M | -27.73%5.99M | -59.44%2.1M | 5.26%14.86M | -8.50%13.35M | -19.25%8.29M | -24.16%5.18M | 42.97%14.11M | 6.62%14.59M | --10.26M |
| Net profit | -0.99%128.51M | 12.84%90M | 27.94%35.88M | 28.35%152.91M | 11.14%129.79M | 2.05%79.77M | 16.02%28.04M | 30.75%119.14M | 23.84%116.78M | 2.74%78.16M |
| Net profit from continuing operation | -0.99%128.51M | 12.84%90M | 27.94%35.88M | 28.35%152.91M | 11.14%129.79M | 2.05%79.77M | 16.02%28.04M | 30.75%119.14M | 23.84%116.78M | --78.16M |
| Net profit of parent company owners | -0.99%128.51M | 12.84%90M | 27.94%35.88M | 28.35%152.91M | 11.14%129.79M | 2.05%79.77M | 16.02%28.04M | 30.75%119.14M | 23.84%116.78M | --78.16M |
| Earning per share | ||||||||||
| Basic earning per share | -1.30%0.76 | 14.89%0.54 | 23.53%0.21 | -1.09%0.91 | -17.20%0.77 | -24.19%0.47 | -10.53%0.17 | 27.78%0.92 | 24.00%0.93 | --0.62 |
| Diluted earning per share | -1.30%0.76 | 14.89%0.54 | 23.53%0.21 | -1.09%0.91 | -17.20%0.77 | -24.19%0.47 | -10.53%0.17 | 27.78%0.92 | --0.93 | --0.62 |
| Other composite income | -91.56%24.9K | 122.76%56.9K | 120.78%30.9K | 647.88%268.26K | 277.00%294.99K | -395.92%-249.97K | -1,176.94%-148.71K | -120.86%-48.96K | -156.50%-166.66K | -50.41K |
| Other composite income of parent company owners | -91.56%24.9K | 122.76%56.9K | 120.78%30.9K | 647.88%268.26K | 277.00%294.99K | -395.92%-249.97K | -1,176.94%-148.71K | -120.86%-48.96K | -156.50%-166.66K | ---50.41K |
| Total composite income | -1.19%128.53M | 13.26%90.06M | 28.74%35.91M | 28.63%153.18M | 11.55%130.09M | 1.80%79.52M | 15.46%27.89M | 30.36%119.09M | 23.27%116.62M | 78.11M |
| Total composite income of parent company owners | -1.19%128.53M | 13.26%90.06M | 28.74%35.91M | 28.63%153.18M | 11.55%130.09M | 1.80%79.52M | 15.46%27.89M | 30.36%119.09M | --116.62M | --78.11M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.